EMA: MAJORITY OF PATIENTS IN STUDY WERE INFECTED WITH THE DELTA VARIANT; BASED ON LAB STUDIES, PAXLOVID ALSO EXPECTED TO BE ACTIVE AGAINST OMICRON
Stock Market News
- Stock Market
- Stock Market News
- Economy
- Ema: Majority Of Patients In Study Were Infected With The Delta…